Skip to main content

Table 3 Risk subsequent muscular involvement according to aldolase at baseline after adjusting for other characteristics at baseline

From: Aldolase predicts subsequent myopathy occurrence in systemic sclerosis

  Hazard ratio (95% CI) P
Aldolase > 9 U/L 10.3 (2.3 to 45.5) < 0.001
Age (per additional year) 0.98 (0.93 to 1.04) 0.68
Female 0.63 (0.07 to 5.18) 0.67
Diffuse form of disease 1.23 (0.27 to 5.49) 0.78
Duration of disease (per additional year) 0.97 (0.90 to 1.05) 0.57
  1. Upper limit of plama aldolase value: 7.0 UI/L